Analysis of PTC patient specimens revealed that TBX3 is highly expressed in cancerous thyroid cells, indicating down regulation of TBX3 could delay the G1/S phase transition, decreased cell growth in vitro and inhibited tumor formation in vivo (114). The gene discussed is TBX3; the disease is neoplasm.